Logo image of VLA.PA

VALNEVA SE (VLA.PA) Stock Price, Quote, News and Overview

EPA:VLA - Euronext Paris - Matif - FR0004056851 - Common Stock - Currency: EUR

2.788  -0.06 (-2.18%)

VLA.PA Quote, Performance and Key Statistics

VALNEVA SE

EPA:VLA (5/30/2025, 7:00:00 PM)

2.788

-0.06 (-2.18%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High4.3
52 Week Low1.73
Market Cap233.00M
Shares83.57M
Float72.28M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-12 2025-08-12
IPO06-28 2007-06-28


VLA.PA short term performance overview.The bars show the price performance of VLA.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40

VLA.PA long term performance overview.The bars show the price performance of VLA.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of VLA.PA is 2.788 EUR. In the past month the price decreased by -4.13%. In the past year, price decreased by -32.23%.

VALNEVA SE / VLA Daily stock chart

VLA.PA Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 17.96 288.63B
AMG.DE AMGEN INC 13.69 135.45B
GIS.DE GILEAD SCIENCES INC 14.12 120.45B
VX1.DE VERTEX PHARMACEUTICALS INC N/A 99.93B
1REGN.MI REGENERON PHARMACEUTICALS 13.73 58.22B
ARGX.BR ARGENX SE 106.84 30.92B
22UA.DE BIONTECH SE-ADR N/A 20.29B
IDP.DE BIOGEN INC 8.2 16.85B
1BMRN.MI BIOMARIN PHARMACEUTICAL INC 33.78 9.98B
1MRNA.MI MODERNA INC N/A 9.15B
0QF.DE MODERNA INC N/A 8.90B
BIO.DE BIOTEST AG 65.85 1.69B

About VLA.PA

Company Profile

VLA logo image Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. The company is headquartered in Saint-Herblain, Pays De La Loire and currently employs 695 full-time employees. The company went IPO on 2007-06-28. The firm's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The firm has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The firm is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.

Company Info

VALNEVA SE

6 rue Alain Bombard

Saint-Herblain PAYS DE LA LOIRE FR

Employees: 713

VLA Company Website

VLA Investor Relations

Phone: 33228073710

VALNEVA SE / VLA.PA FAQ

What is the stock price of VALNEVA SE today?

The current stock price of VLA.PA is 2.788 EUR. The price decreased by -2.18% in the last trading session.


What is the ticker symbol for VALNEVA SE stock?

The exchange symbol of VALNEVA SE is VLA and it is listed on the Euronext Paris - Matif exchange.


On which exchange is VLA.PA stock listed?

VLA.PA stock is listed on the Euronext Paris - Matif exchange.


What is the price forecast or stock price prediction for VALNEVA SE stock?

12 analysts have analysed VLA.PA and the average price target is 7.43 EUR. This implies a price increase of 166.67% is expected in the next year compared to the current price of 2.788. Check the VALNEVA SE stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is VALNEVA SE worth?

VALNEVA SE (VLA.PA) has a market capitalization of 233.00M EUR. This makes VLA.PA a Micro Cap stock.


How many employees does VALNEVA SE have?

VALNEVA SE (VLA.PA) currently has 713 employees.


What are the support and resistance levels for VALNEVA SE (VLA.PA) stock?

VALNEVA SE (VLA.PA) has a support level at 2.61 and a resistance level at 2.8. Check the full technical report for a detailed analysis of VLA.PA support and resistance levels.


Is VALNEVA SE (VLA.PA) expected to grow?

The Revenue of VALNEVA SE (VLA.PA) is expected to grow by 6.9% in the next year. Check the estimates tab for more information on the VLA.PA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy VALNEVA SE (VLA.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does VALNEVA SE (VLA.PA) stock pay dividends?

VLA.PA does not pay a dividend.


When does VALNEVA SE (VLA.PA) report earnings?

VALNEVA SE (VLA.PA) will report earnings on 2025-08-12.


What is the Price/Earnings (PE) ratio of VALNEVA SE (VLA.PA)?

VALNEVA SE (VLA.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.54).


VLA.PA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

VLA.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to VLA.PA. VLA.PA has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

VLA.PA Financial Highlights

Over the last trailing twelve months VLA.PA reported a non-GAAP Earnings per Share(EPS) of -0.54. The EPS decreased by -184.21% compared to the year before.


Industry RankSector Rank
PM (TTM) 15.08%
ROA 7.48%
ROE 20.65%
Debt/Equity 1.06
Chartmill High Growth Momentum
EPS Q2Q%-114.63%
Sales Q2Q%50.31%
EPS 1Y (TTM)-184.21%
Revenue 1Y (TTM)10.32%

VLA.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to VLA.PA. The Buy consensus is the average rating of analysts ratings from 12 analysts.

For the next year, analysts expect an EPS growth of -597.38% and a revenue growth 6.9% for VLA.PA


Ownership
Inst Owners29.31%
Ins Owners0.18%
Short Float %N/A
Short RatioN/A
Analysts
Analysts83.33
Price Target7.43 (166.5%)
EPS Next Y-597.38%
Revenue Next Year6.9%